Cargando…
Absence of AKT1 Mutations in Glioblastoma
BACKGROUND: Oncogenic activation of the PI3K signalling pathway plays a pivotal role in the development of glioblastoma multiforme (GBM). A central node in PI3K downstream signalling is controlled by the serine-threonine kinase AKT1. A somatic mutation affecting residue E17 of the AKT1 gene has rece...
Autores principales: | Bleeker, Fonnet E., Lamba, Simona, Zanon, Carlo, van Tilborg, Angela A., Leenstra, Sieger, Troost, Dirk, Hulsebos, Theo, Vandertop, W. Peter, Bardelli, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680963/ https://www.ncbi.nlm.nih.gov/pubmed/19461960 http://dx.doi.org/10.1371/journal.pone.0005638 |
Ejemplares similares
-
Mutational profiling of kinases in glioblastoma
por: Bleeker, Fonnet E, et al.
Publicado: (2014) -
Recent advances in the molecular understanding of glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2012) -
The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010) -
Mutational Profile of GNAQ
(Q209) in Human Tumors
por: Lamba, Simona, et al.
Publicado: (2009) -
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors
por: Fabro, Federica, et al.
Publicado: (2022)